Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. Academic Article uri icon

Overview

abstract

  • OBJECTIVES: To evaluate variant histologies (VHs) for disease-specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC). MATERIALS AND METHODS: We analysed a multi-institutional cohort of 1082 patients treated with upfront RC for cT1-4aN0M0 urothelial BCa at eight centres. Univariable and multivariable Cox' regression analyses were used to assess the effect of different VHs on DSS in overall cohort and three stage-based analyses. The stages were defined as 'organ-confined' (≤pT2N0), 'locally advanced' (pT3-4N0) and 'node-positive' (pTanyN1-3). RESULTS: Overall, 784 patients (72.5%) had pure urothelial carcinoma (UC), while the remaining 298 (27.5%) harboured a VH. Squamous differentiation was the most common VH, observed in 166 patients (15.3%), followed by micropapillary (40 patients [3.7%]), sarcomatoid (29 patients [2.7%]), glandular (18 patients [1.7%]), lymphoepithelioma-like (14 patients [1.3%]), small-cell (13 patients [1.2%]), clear-cell (eight patients [0.7%]), nested (seven patients [0.6%]) and plasmacytoid VH (three patients [0.3%]). The median follow-up was 2.3 years. Overall, 534 (49.4%) disease-related deaths occurred. In uni- and multivariable analyses, plasmacytoid and small-cell VHs were associated with worse DSS in the overall cohort (both P = 0.04). In univariable analyses, sarcomatoid VH was significantly associated with worse DSS, while lymphoepithelioma-like VH had favourable DSS compared to pure UC. Clear-cell (P = 0.015) and small-cell (P = 0.011) VH were associated with worse DSS in the organ-confined and node-positive cohorts, respectively. CONCLUSIONS: More than 25% of patients harboured a VH at time of RC. Compared to pure UC, clear-cell, plasmacytoid, small-cell and sarcomatoid VHs were associated with worse DSS, while lymphoepithelioma-like VH was characterized by a DSS benefit. Accurate pathological diagnosis of VHs may ensure tailored counselling to identify patients who require more intensive management.

authors

  • Claps, Francesco
  • van de Kamp, Maaike W
  • Mayr, Roman
  • Bostrom, Peter J
  • Shariat, Shahrokh
  • Hippe, Katrin
  • Bertz, Simone
  • Neuzillet, Yann
  • Sanders, Joyce
  • Otto, Wolfgang
  • van der Heijden, Michiel S
  • Jewett, Michael A S
  • Stöhr, Robert
  • Zlotta, Alexandre R
  • Trombetta, Carlo
  • Eckstein, Markus
  • Mertens, Laura S
  • Burger, Maximilian
  • Soorojebally, Yanish
  • Wullich, Bernd
  • Bartoletti, Riccardo
  • Radvanyi, François
  • Pavan, Nicola
  • Sirab, Nanour
  • Mir, M Carmen
  • Pouessel, Damien
  • van der Kwast, Theo H
  • Hartmann, Arndt
  • Lotan, Yair
  • Bussani, Rossana
  • Allory, Yves
  • van Rhijn, Bas W G

publication date

  • February 20, 2023

Research

keywords

  • Carcinoma, Transitional Cell
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 85148512735

Digital Object Identifier (DOI)

  • 10.1111/bju.15984

PubMed ID

  • 36748180

Additional Document Info

volume

  • 132

issue

  • 2